Value of Biomarkers of Brain Injury for Predicting Psycho-cognitive Sequelae Secondary to Sepsis: a Prospective Multicenter Study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 210
- 试验地点
- 1
- 主要终点
- Cognitive function impairment assessed by the Montreal Cognitive Assessment (MoCA) score at 3 months
研究概览
简要总结
To evaluate the value of biomarkers of neuronal and glial injury for predicting cognitive impairment (memory impairment assessed by a MoCA score < 26/30) at 3 months in patient admitted in the intensive care unit for a sepsis or a septic shock.
详细描述
Sepsis is a major cause of admission to intensive care units and is responsible for approximately 11 million deaths worldwide each year. It may be complicated by an acute brain dysfunction known as sepsis-associated encephalopathy (SAE), which affects about 50% of patients and typically manifests as delirium or coma. The diagnosis of SAE is primarily clinical, with EEG and brain MRI providing supportive information. Risk factors for SAE are mainly related to patient characteristics, including advanced age, chronic kidney disease, and pre-existing neurodegenerative or cognitive disorders. The pathophysiology of SAE involves three major mechanisms: neuroinflammation, endothelial dysfunction with blood-brain barrier disruption, and mitochondrial dysfunction leading to neuronal injury. These mechanisms likely explain both acute neurological symptoms and long-term psycho-cognitive sequelae. Following sepsis, 30-60% of patients develop psychiatric disorders and cognitive impairments comparable to those observed after moderate traumatic brain injury or early Alzheimer's disease. These sequelae are part of post-intensive care syndrome (PICS), supporting the need for structured post-ICU follow-up. However, the optimal target population and organization of such follow-up remain unclear, as some studies have reported reduced quality of life in patients receiving long-term follow-up. Identifying early biomarkers predictive of psycho-cognitive outcomes is therefore crucial, as current data on neuronal and glial biomarkers remain limited. Such biomarkers could improve prognostication, guide cognitive rehabilitation and psychological support, and contribute to the development of future neuroprotective strategies.
Primary objective:
To evaluate the value of biomarkers of brain injury for predicting cognitive impairment (memory impairment assessed by a MoCA score < 26/30) at 3 months.
Secondary objectives:
- To evaluate the value of brain injury biomarkers for predicting delirium in the ICU, including hypoactive, hyperactive, and mixed phenotypes
- To assess the association between brain injury biomarkers and the duration of delirium in the ICU
- To evaluate the value of brain injury biomarkers for predicting psychological sequelae (anxiety, post-traumatic stress disorder, and depression) at 3 months
- To evaluate the value of brain injury biomarkers for predicting functional neurological outcomes using the Glasgow Outcome Scale-Extended at ICU discharge and at 3 months
- To assess the association between brain injury biomarkers and Post-Intensive Care Syndrome (PICS)
- To assess the association between brain injury biomarkers and EEG abnormalities in the ICU
- To assess the association between brain injury biomarkers and MRI abnormalities at 3 months
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults aged 18-80 years.
- •Admission to a medical or mixed ICU.
- •Sepsis or septic shock according to Sepsis-3 criteria.
- •ICU admission for less than 24 hours.
- •Need for invasive or non-invasive mechanical ventilation and/or vasopressor support.
- •Informed consent obtained from the patient or legal representative.
排除标准
- •Moribund patients.
- •Age >80 years.
- •Patients under legal guardianship.
- •History of schizophrenia or bipolar disorder.
- •Pregnancy.
- •No health insurance coverage.
- •Previous inclusion in the study.
- •Refusal to participate.
结局指标
主要结局
Cognitive function impairment assessed by the Montreal Cognitive Assessment (MoCA) score at 3 months
时间窗: 3 months
Montreal Cognitive Assessment (MoCA) ranges from 0 to 30 points, with higher scores indicating better cognitive performance. Cognitive impairment will be defined as a MoCA score \<26/30.
次要结局
- Type of ICU delirium: hypoactive, hyperactive, or mixed(3 months)
- Psychiatric disorders (anxiety, depression : ( 0 =min; 21 =max) , or PTSD)(3 months)
- Glasgow Outcome Scale-Extended (GOSE)(3 months)
- Coma- and/or delirium-free days(Day 10 after inclusion)
- Duration of delirium in the intensive care unit (ICU)(3 months)
- Delirium duration(3 months)
- Delirium phenotype(3 months)
- Psychiatric outcomes(3 months)
- Functional outcome(3 months)
- PICS : Post-Intensive Care Syndrome (PICS)(3 months)
- Neurological, psychiatric, or rehabilitation follow-up proposed to the patient(3 months)